Intravitreal aflibercept for neovascular AMD in the very elderly neovascular AMD patients: UK Multi-centre Real World Outcome

被引:0
|
作者
Talks, James [1 ]
Sivaprasad, Sobha [2 ]
机构
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Ctr Eye, Newcastle Upon Tyne, Tyne & Wear, England
[2] Moorfields Eye Hosp, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
911
引用
收藏
页数:2
相关论文
共 50 条
  • [41] The effect of two different intravitreal injection techniques on frequency of vitreous reflux and on treatment response in neovascular AMD patients
    Erdem, B.
    Kapti, H. B.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (04): : 405 - 412
  • [42] REAL-WORLD VISUAL OUTCOMES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION RECEIVING INTRAVITREAL AFLIBERCEPT AT FIXED INTERVALS AS PER UK LICENSE
    Mehta, Hemal
    Nguyen, Vuong
    Ozturk, Mehmet
    Harris, Martin
    Barthelmes, Daniel
    Gillies, Mark
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 135 - 136
  • [43] Retrospective analysis of the effect of aflibercept loading dose on the retinal vessel diameters in patients with treatment-naive neovascular AMD
    Tetikoglu, Mehmet
    Kurt, Muhammed Mustafa
    Sagdik, Haci Murat
    Aktas, Serdar
    Yildirim, Medine Asli
    Ozcura, Fatih
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2018, 37 (01) : 84 - 89
  • [44] Dynamics and patterns of recurrence in neovascular AMD during real-world management using automated fluid monitoring
    Prenner, Veronika
    Schmidt-Erfurth, Ursula
    Fuchs, Philipp
    Leingang, Oliver
    Coulibaly, Leonard Mana
    Bogunovic, Hrvoje
    Barthelmes, Daniel
    Reiter, Gregor Sebastian
    [J]. HELIYON, 2024, 10 (10)
  • [45] Effect of Risk Alleles in CFH, C3, and VEGFA on the Response to Intravitreal Bevacizumab in Tunisian patients with neovascular AMD
    Imen, Habibi
    Kort, Fedra
    Sfar, Imen
    Chebil, Ahmed
    Bouraoui, Rim
    Ben Abdallah, Taieb
    El Matri, Leila
    Gorgi, Yousr
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [46] Quantification of Change in Pigment Epithelial Detachment Volume and Morphology After Transition to Intravitreal Aflibercept in Eyes With Recalcitrant Neovascular AMD: 18-Month Results
    Kanesa-Thasan, Aditya
    Grewal, Dilraj S.
    Gill, Manjot K.
    Lyon, Alice T.
    Mirza, Rukhsana G.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (06): : 638 - 641
  • [47] Evaluation of contrast sensitivity and other visual function outcomes in neovascular AMD patients following treatment switch to aflibercept from ranibizumab
    Nixon, Don
    Flinn, Nicholas
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [48] Anti VEGF Therapy Under Real-Life Conditions: Adherance Determines Long Term Outcome in Neovascular AMD
    Sachs, H. G.
    Wilke, R. G. H.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (08) : 958 - 964
  • [49] Real World Data Comparison of Standard Care vs SDM Laser Vision Protection Therapy for Prevention of Neovascular AMD
    Luttrull, Jeffrey K.
    Gray, Gerry
    [J]. CLINICAL OPHTHALMOLOGY, 2022, 16 : 1555 - 1568
  • [50] Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license
    Ozturk, Mehmet
    Harris, Martin
    Vuong Nguyen
    Barthelmes, Daniel
    Gillies, Mark C.
    Mehta, Hemal
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)